|
Active Ingredient
|
TRIAMCINOLONE
|
|
Therapeutic Class
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
Indications
|
Treatment of seasonal and perennial allergic rhinitis.
|
|
Caution
|
Headache occurred in 18% of patients receiving intranasal triamcinolone. Other adverse effects included nasal irritation, dry mucous membranes, congestion, throatdiscomfort, sneezing. No More ...
|
|
Dose Range
|
Adults and Children 12 years and over: 2 sprays in each nostril once daily, decrease to one spray once daily as a maintenance dose. Pediatric (6-12 years): 1 sp ray into each nostril once daily. See BDS supply protocols pg. 11.
|
|
Drug Interactions
|
|
|
Pregnancy
|
|
|
Breast Feeding
|
|
